Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The importance of the bacterial spectrum in the clinical diagnostics and management of patients with spontaneous pyogenic spondylodiscitis and isolated spinal epidural empyema: a 20-year cohort study at a single spine center.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central, [2001-
    • الموضوع:
    • نبذة مختصرة :
      Background: Personalized clinical management of spondylodiscitis (SD) and isolated spinal epidural empyema (ISEE) is challenging due to limited evidence of microbiologic findings and their clinical impact during the clinical course of the disease. We aimed to characterize clinico-microbiological and imaging phenotypes of SD and ISEE to provide useful insights that could improve outcomes and potentially modify guidelines.
      Methods: We performed chart review and collected data on the following parameters: bacterial antibiogram-resistogram, type of primary spinal infection, location of spinal infection, source of infection, method of detection, clinical complications (sepsis, septic embolism, and endocarditis), length of hospital and intensive care unit (ICU) stay, relapse rate, and disease-related mortality in patients with proven pyogenic SD and ISEE treated surgically in a university hospital in Germany between 2002 and 2022.
      Results: We included data from 187 patients (125 SD, 66.8% and 62 ISEE, 33.2%). Gram-positive bacteria (GPB) were overall more frequently detected than gram-negative bacteria (GNB) (GPB: 162, 86.6% vs. GNB: 25, 13.4%, p < 0.001). Infective endocarditis was caused only by GPB (GPB: 23, 16.5% vs. GNB: 0, 0.0%, p = 0.046). Methicillin-susceptible Staphylococcus aureus was the most frequently isolated strain (MSSA: n = 100, 53.5%), occurred more frequently in the cervical spine compared to other bacteria (OB) (MSSA: 41, 41.0% vs. OB: 18, 20.7%, p = 0.004) and was most frequently detected in patients with skin infection as the primary source of infection (MSSA: 26, 40.6% vs. OB: 11, 16.7%, p = 0.002). Streptococcus spp. and Enterococcus spp. (SE: n = 31, 16.6%) were more often regarded as the cause of endocarditis (SE: 8, 27.6% vs. OB: 15, 11.4%, p = 0.037) and were less frequently detected in intraoperative specimens (SE: 19, 61.3% vs. OB: 138, 88.5%, p < 0.001). Enterobacterales (E: n = 20, 10.7%) were identified more frequently in urinary tract infections (E: 9, 50.0% vs. OB: 4, 3.6%, p < 0.001). Coagulase-negative Staphylococci (CoNS: n = 20, 10.7%) were characterized by a lower prevalence of sepsis (CoNS: 4, 20.0% vs. OB: 90, 53.9%, p = 0.004) and were more frequently detected in intraoperative specimens (CoNS: 20, 100. 0% vs. OB: 137, 82.0%, p = 0.048). Moreover, CoNS-associated cases showed a shorter length of ICU stay (CoNS: 2 [1-18] days vs. OB: 6 [1-53] days, median [interquartile range], p = 0.037), and occurred more frequently due to foreign body-associated infections (CoNS: 8, 61.5% vs. OB: 15, 12.8%, p = 0.008). The presence of methicillin-resistant Staphylococcus aureus (MRSA) prolonged hospital stay by 56 [24-58] days and ICU stay by 16 [1-44] days, whereas patients with Pseudomonas aeruginosa spent only 20 [18-29] days in the hospital and no day in the ICU 0 [0-5] days.
      Conclusions: Our retrospective cohort study identified distinct bacterial-specific manifestations in pyogenic SD and ISEE regarding clinical course, neuroanatomic targets, method of pathogen detection, and sources of infection. The clinico-microbiological patterns varied depending on the specific pathogens.
      (© 2023. The Author(s).)
    • References:
      Eur Spine J. 2013 Aug;22(8):1837-44. (PMID: 23247861)
      Rev Infect Dis. 1979 Sep-Oct;1(5):754-76. (PMID: 542761)
      West J Emerg Med. 2021 Aug 30;22(5):1156-1166. (PMID: 34546893)
      Dtsch Arztebl Int. 2008 Mar;105(10):181-7. (PMID: 19629222)
      Dtsch Arztebl Int. 2017 Dec 25;114(51-52):875-882. (PMID: 29321098)
      J Emerg Med. 2004 Apr;26(3):285-91. (PMID: 15028325)
      GMS Hyg Infect Control. 2014 Sep 30;9(3):Doc23. (PMID: 25285267)
      JAMA. 2007 Oct 17;298(15):1763-71. (PMID: 17940231)
      J Antimicrob Chemother. 2010 Nov;65 Suppl 3:iii11-24. (PMID: 20876624)
      J Infect. 2016 Jul;73(1):91-3. (PMID: 27066877)
      Infection. 2021 Oct;49(5):1017-1027. (PMID: 34254283)
      J Neurosurg Spine. 2014 Mar;20(3):344-9. (PMID: 24359002)
      Lancet. 2015 Mar 7;385(9971):875-82. (PMID: 25468170)
      Eur Spine J. 2018 Jun;27(Suppl 2):229-236. (PMID: 29667140)
      Int J Antimicrob Agents. 2019 Aug;54(2):125-133. (PMID: 31202920)
      Epidemiol Infect. 2008 May;136(5):653-60. (PMID: 17568478)
      Eur Radiol. 2004 Mar;14 Suppl 3:E43-52. (PMID: 14749956)
      Acta Orthop Scand. 1998 Oct;69(5):513-7. (PMID: 9855235)
      Infect Dis Clin North Am. 2017 Jun;31(2):279-297. (PMID: 28366222)
      Clin Microbiol Infect. 2014 Jul;20(7):587-8. (PMID: 24930666)
      Orthopedics. 1999 Aug;22(8):758-65. (PMID: 10465488)
      World Neurosurg. 2017 Jul;103:664-670. (PMID: 28457929)
      Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):117-128. (PMID: 30977878)
      Infection. 2014 Jun;42(3):503-10. (PMID: 24446233)
      Eur Spine J. 2019 Apr;28(4):751-761. (PMID: 30317386)
      Clin Infect Dis. 2015 Sep 15;61(6):859-63. (PMID: 26316526)
      Eur Spine J. 2017 Oct;26(Suppl 4):479-488. (PMID: 28324216)
      Eur Spine J. 2015 Mar;24(3):571-6. (PMID: 25432097)
      PLoS One. 2017 Dec 5;12(12):e0188470. (PMID: 29206837)
      Joint Bone Spine. 2001 Dec;68(6):504-9. (PMID: 11808988)
      Clin Infect Dis. 1999 Aug;29(2):339-45. (PMID: 10476739)
      Semin Arthritis Rheum. 2002 Feb;31(4):271-8. (PMID: 11836660)
      Virulence. 2021 Dec;12(1):547-569. (PMID: 33522395)
      Eur J Radiol. 2004 May;50(2):120-33. (PMID: 15081128)
      Intern Emerg Med. 2017 Dec;12(8):1179-1183. (PMID: 28779448)
      Am J Med. 2005 Nov;118(11):1287. (PMID: 16271915)
    • Contributed Indexing:
      Keywords: Bacterial spectrum; Isolated spinal epidural empyema; Osteomyelitis; Spondylodiscitis; Staphylococcus aureus
    • الرقم المعرف:
      0 (Anti-Bacterial Agents)
    • الموضوع:
      Date Created: 20240103 Date Completed: 20240105 Latest Revision: 20240106
    • الموضوع:
      20240106
    • الرقم المعرف:
      PMC10762996
    • الرقم المعرف:
      10.1186/s12879-023-08946-x
    • الرقم المعرف:
      38166791